A neolignan from Connarus tuberosus as an allosteric GABAA receptor modulator at the neurosteroid binding site - 28/03/23

Abstract |
In a screening of a small library of extracts from plants of the Amazonian and Cerrado biomes, a hexane extract of Connarus tuberosus roots was found to significantly potentiate the GABA induced fluorescence in a fluorescence (FLIPR) assay in CHO cells stably expressing the α1β2γ2 subtype of human GABAA receptors. With the aid of HPLC-based activity profiling the activity was linked to the neolignan connarin. In CHO cells the activity of connarin was not abolished by increasing concentrations of flumazenil, while the effect of diazepam was increased by increasing concentrations of connarin. The effect of connarin was abolished by pregnenolone sulfate (PREGS) in a concentration-dependent manner, and the effect of allopregnanolone was further increased by increasing concentrations of connarin. In a two-microelectrode voltage clamp assay with Xenopus laevis oocytes transiently expressing GABAA receptors composed of human α1β2γ2S and α1β2 subunits connarin potentiated the GABA-induced currents, with EC50 values of 1.2 ± 0.3 μM (α1β2γ2S) and 1.3 ± 0.4 μM (α1β2), and with a maximum enhancement of currents Emax of 1959 ± 70% (α1β2γ2S) and 185 ± 48% (α1β2). The activation induced by connarin was abolished by increasing concentrations of PREGS.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Connarus tuberosus potentiated the GABA-induced signal in FLIPR assay in CHO cells. |
• | Neolignan connarin was identified as active compound. |
• | Connarin strongly potentiated GABA-induced Cl- currents in Xenopus oocyte assay. |
• | Connarin interacts with neurosteroid binding sites of GABAA receptors. |
Keywords : Connarus tuberosus, Connaraceae, Brazilian Cerrado, Neoflavonoid, GABAA receptor
Plan
Vol 161
Article 114498- mai 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?